» Articles » PMID: 29760448

The Gut Microbiota and the Brain-gut-kidney Axis in Hypertension and Chronic Kidney Disease

Overview
Journal Nat Rev Nephrol
Specialty Nephrology
Date 2018 May 16
PMID 29760448
Citations 313
Authors
Affiliations
Soon will be listed here.
Abstract

Crosstalk between the gut microbiota and the host has attracted considerable attention owing to its involvement in diverse diseases. Chronic kidney disease (CKD) is commonly associated with hypertension and is characterized by immune dysregulation, metabolic disorder and sympathetic activation, which are all linked to gut dysbiosis and altered host-microbiota crosstalk. In this Review, we discuss the complex interplay between the brain, the gut, the microbiota and the kidney in CKD and hypertension and explain our brain-gut-kidney axis hypothesis for the pathogenesis of these diseases. Consideration of the role of the brain-gut-kidney axis in the maintenance of normal homeostasis and of dysregulation of this axis in CKD and hypertension could lead to the identification of novel therapeutic targets. In addition, the discovery of unique microbial communities and their associated metabolites and the elucidation of brain-gut-kidney signalling are likely to fill fundamental knowledge gaps leading to innovative research, clinical trials and treatments for CKD and hypertension.

Citing Articles

Mechanisms of action of intestinal microorganisms and advances in head and neck tumors.

Xialu S, Faqiang M Discov Oncol. 2025; 16(1):303.

PMID: 40072772 PMC: 11903988. DOI: 10.1007/s12672-025-02035-y.


Advances in kidney disease: pathogenesis and therapeutic targets.

Boima V, Agyekum A, Ganatra K, Agyekum F, Kwakyi E, Inusah J Front Med (Lausanne). 2025; 12:1526090.

PMID: 40027896 PMC: 11868101. DOI: 10.3389/fmed.2025.1526090.


Gut-X axis.

Lin X, Yu Z, Liu Y, Li C, Hu H, Hu J Imeta. 2025; 4(1):e270.

PMID: 40027477 PMC: 11865426. DOI: 10.1002/imt2.270.


Relationship between dietary consumption of live microbes with mortality in adults with chronic kidney disease.

Han J, Zhang H, Li X, Tang Y, Du Y, Zhang H J Nephrol. 2025; .

PMID: 39939503 DOI: 10.1007/s40620-025-02212-w.


A metagenome-wide study of the gut virome in chronic kidney disease.

Zhang P, Guo R, Ma S, Jiang H, Yan Q, Li S Theranostics. 2025; 15(5):1642-1661.

PMID: 39897560 PMC: 11780533. DOI: 10.7150/thno.101601.


References
1.
Kaur J, Young B, Fadel P . Sympathetic Overactivity in Chronic Kidney Disease: Consequences and Mechanisms. Int J Mol Sci. 2017; 18(8). PMC: 5578072. DOI: 10.3390/ijms18081682. View

2.
Jenkins D, Kendall C, Vuksan V, Vidgen E, Parker T, Faulkner D . Soluble fiber intake at a dose approved by the US Food and Drug Administration for a claim of health benefits: serum lipid risk factors for cardiovascular disease assessed in a randomized controlled crossover trial. Am J Clin Nutr. 2002; 75(5):834-9. DOI: 10.1093/ajcn/75.5.834. View

3.
Minot S, Grunberg S, Wu G, Lewis J, Bushman F . Hypervariable loci in the human gut virome. Proc Natl Acad Sci U S A. 2012; 109(10):3962-6. PMC: 3309749. DOI: 10.1073/pnas.1119061109. View

4.
CRABBE P, Bazin H, EYSSEN H, Heremans J . The normal microbial flora as a major stimulus for proliferation of plasma cells synthesizing IgA in the gut. The germ-free intestinal tract. Int Arch Allergy Appl Immunol. 1968; 34(4):362-75. DOI: 10.1159/000230130. View

5.
Kurella M, Yaffe K, Shlipak M, Wenger N, Chertow G . Chronic kidney disease and cognitive impairment in menopausal women. Am J Kidney Dis. 2005; 45(1):66-76. DOI: 10.1053/j.ajkd.2004.08.044. View